STH (saitohin) is a nuclear and cytoplasmic protein involved in mRNA splicing regulation. Based on available evidence, STH functions in positive regulation of mRNA splicing via the spliceosome [GO annotations provided], with localization to the nucleus, nucleoplasm, cytosol, and perinuclear cytoplasmic regions, suggesting roles in both nuclear splicing and cytoplasmic processes. STH is notable for its association with neurodegenerative disease susceptibility. The MAPT_238bp/STH Q7R polymorphisms—which are part of the extended tau haplotype (H1)—show significant associations with Parkinson's disease risk across multiple genetic models in meta-analytic studies 1. This suggests STH variants may modulate neurodegenerative disease susceptibility, though the mechanistic basis of this association requires clarification. The protein exhibits protein binding capacity [GO annotations], indicating potential interactions with splicing machinery or regulatory factors. Clinical significance centers on STH's role as a genetic risk factor for Parkinson's disease, where specific polymorphisms influence disease susceptibility, particularly in Caucasian populations 1. However, comprehensive functional characterization of STH's specific molecular mechanisms, tissue-specific roles beyond neuronal contexts, and the precise pathogenic mechanisms linking STH variants to neurodegeneration remain incompletely understood and require further investigation.